# Efficacy and Safety of Hemorrane Plus Versus Hemorrane and Versus Placebo in Patients With Uncomplicated Haemorrhoids

> **NCT05788497** · PHASE3 · TERMINATED · sponsor: **Faes Farma, S.A.** · enrollment: 21 (actual)

## Conditions studied

- Haemorrhoids Without Complication

## Interventions

- **DRUG:** Hemorrane plus
- **DRUG:** Hemorrane
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05788497
- **Lead sponsor:** Faes Farma, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-03-30
- **Primary completion:** 2024-01-04
- **Final completion:** 2024-01-04
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Recruitment failure
- **Last updated:** 2024-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05788497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05788497, "Efficacy and Safety of Hemorrane Plus Versus Hemorrane and Versus Placebo in Patients With Uncomplicated Haemorrhoids". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05788497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*